Xencor, Inc.
Heterodimeric human IgG1 polypeptides with isoelectric point modifications

Abstract:

The invention relates generally to compositions and methods for purifying the desired species from a mixture of desired heterodimer and contaminating homodimer immunoglobulin variants by modifying the isoelectric point(s) of the individual chains.